US Stock MarketDetailed Quotes

Adaptive Biotechnologies (ADPT)

Watchlist

12.830
-0.350-2.66%

Close May 15 16:00 ET

12.700
-0.130-1.01%

Pre 07:43 ET

2.05BMarket Cap-40.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptive Biotechnologies (ADPT) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

66.52%-9.54M

51.70%-45.99M

116.45%2.06M

73.67%-7.13M

28.16%-12.43M

25.73%-28.48M

39.09%-95.21M

53.62%-12.49M

42.03%-27.07M

26.55%-17.3M

Net income from continuing operations

32.90%-20.02M

62.75%-59.46M

59.73%-13.58M

129.74%9.55M

44.66%-25.59M

37.24%-29.83M

29.16%-159.6M

51.46%-33.72M

36.22%-32.1M

3.27%-46.25M

Depreciation and amortization

-18.90%3.84M

-7.39%17.83M

-5.69%4.2M

-4.05%4.41M

-10.01%4.5M

-9.26%4.73M

-13.38%19.26M

-17.51%4.45M

-20.34%4.59M

-11.50%5M

Other non cash items

-51.68%807K

-51.83%3.87M

-54.65%843K

-97.02%56K

-32.50%1.3M

-29.48%1.67M

-35.15%8.04M

-14.45%1.86M

-49.35%1.88M

-36.73%1.93M

Change In working capital

61.00%-6.3M

-230.97%-57.77M

-180.28%-2.45M

-159.98%-33.87M

-287.72%-5.31M

-56.64%-16.14M

62.21%-17.45M

186.93%3.05M

30.13%-13.03M

529.40%2.83M

-Change in receivables

209.98%2.05M

-130.93%-8.65M

-516.69%-5.54M

89.70%-536K

-110.95%-702K

54.00%-1.86M

-284.25%-3.74M

86.71%-899K

-1,658.08%-5.2M

1,132.37%6.41M

-Change in inventory

-598.11%-1.32M

-118.58%-998K

-100.30%-10K

-179.38%-1.35M

111.61%95K

-76.24%264K

289.29%5.37M

-14.96%3.38M

721.61%1.7M

-1,358.46%-818K

-Change in prepaid assets

-268.51%-824K

-2,187.95%-1.73M

-16.77%799K

-80.41%-2.52M

50.20%-497K

-67.83%489K

104.30%83K

-52.80%960K

67.69%-1.4M

-239.00%-998K

-Change in payables and accrued expense

22.28%-7.51M

-0.89%665K

-72.68%1.17M

10,093.22%5.9M

703.19%3.27M

-145.24%-9.67M

112.41%671K

-20.13%4.26M

97.90%-59K

-94.87%407K

-Change in other working capital

124.33%1.31M

-137.22%-47.06M

124.47%1.14M

-338.56%-35.36M

-243.29%-7.47M

-8.56%-5.37M

47.85%-19.84M

42.51%-4.65M

30.31%-8.06M

71.57%-2.18M

Cash from discontinued investing activities

Operating cash flow

66.52%-9.54M

51.70%-45.99M

116.45%2.06M

73.67%-7.13M

28.16%-12.43M

25.73%-28.48M

39.09%-95.21M

53.62%-12.49M

42.03%-27.07M

26.55%-17.3M

Investing cash flow

Cash flow from continuing investing activities

-64.25%9.14M

-51.22%37.95M

-137.31%-8.25M

226.90%17.28M

-43.07%3.35M

-42.54%25.57M

-40.00%77.79M

589.71%22.12M

-79.77%5.29M

-84.25%5.88M

Net PPE purchase and sale

36.78%-796K

19.24%-2.96M

-695.00%-636K

-18.90%-409K

62.12%-655K

16.68%-1.26M

65.75%-3.66M

93.84%-80K

87.62%-344K

53.23%-1.73M

Net investment purchase and sale

-62.96%9.94M

-49.78%40.91M

-134.31%-7.62M

214.19%17.69M

-47.40%4M

-41.69%26.83M

-41.96%81.46M

392.76%22.2M

-80.53%5.63M

-81.46%7.61M

Cash from discontinued investing activities

Investing cash flow

-64.25%9.14M

-51.22%37.95M

-137.31%-8.25M

226.90%17.28M

-43.07%3.35M

-42.54%25.57M

-40.00%77.79M

589.71%22.12M

-79.77%5.29M

-84.25%5.88M

Financing cash flow

Cash flow from continuing financing activities

37.59%7.5M

12,515.35%30.4M

16,953.54%21.66M

4,110.00%1.68M

5,266.67%1.61M

12,288.64%5.45M

-89.27%241K

45.98%127K

135.29%40K

-97.96%30K

Proceeds from stock option exercised by employees

-7.82%5.03M

7,318.67%17.88M

7,092.13%9.13M

4,110.00%1.68M

5,266.67%1.61M

12,288.64%5.45M

-89.27%241K

45.98%127K

135.29%40K

-97.96%30K

Net other financing activities

--2.48M

--12.52M

----

Cash from discontinued financing activities

Financing cash flow

37.59%7.5M

12,515.35%30.4M

16,953.54%21.66M

4,110.00%1.68M

5,266.67%1.61M

12,288.64%5.45M

-89.27%241K

45.98%127K

135.29%40K

-97.96%30K

Net cash flow

Beginning cash position

44.01%73.18M

-25.26%50.82M

40.58%57.72M

-26.94%45.88M

-28.09%53.36M

-25.26%50.82M

-26.43%68M

-55.19%41.06M

-44.01%62.8M

-23.45%74.2M

Current changes in cash

179.76%7.11M

230.20%22.37M

58.49%15.46M

154.47%11.84M

34.42%-7.47M

-59.03%2.54M

29.69%-17.18M

141.27%9.76M

-5.89%-21.74M

-174.80%-11.4M

End cash Position

50.48%80.29M

44.01%73.18M

40.58%57.72M

-26.94%45.88M

-28.09%53.36M

-25.26%50.82M

-55.19%41.06M

-44.01%62.8M

Free cash flow

65.26%-10.33M

50.50%-48.95M

111.29%1.42M

72.51%-7.54M

31.25%-13.09M

25.39%-29.74M

40.80%-98.88M

55.47%-12.57M

44.59%-27.41M

30.17%-19.03M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	66.52%-9.54M	51.70%-45.99M	116.45%2.06M	73.67%-7.13M	28.16%-12.43M	25.73%-28.48M	39.09%-95.21M	53.62%-12.49M	42.03%-27.07M	26.55%-17.3M
Net income from continuing operations	32.90%-20.02M	62.75%-59.46M	59.73%-13.58M	129.74%9.55M	44.66%-25.59M	37.24%-29.83M	29.16%-159.6M	51.46%-33.72M	36.22%-32.1M	3.27%-46.25M
Depreciation and amortization	-18.90%3.84M	-7.39%17.83M	-5.69%4.2M	-4.05%4.41M	-10.01%4.5M	-9.26%4.73M	-13.38%19.26M	-17.51%4.45M	-20.34%4.59M	-11.50%5M
Other non cash items	-51.68%807K	-51.83%3.87M	-54.65%843K	-97.02%56K	-32.50%1.3M	-29.48%1.67M	-35.15%8.04M	-14.45%1.86M	-49.35%1.88M	-36.73%1.93M
Change In working capital	61.00%-6.3M	-230.97%-57.77M	-180.28%-2.45M	-159.98%-33.87M	-287.72%-5.31M	-56.64%-16.14M	62.21%-17.45M	186.93%3.05M	30.13%-13.03M	529.40%2.83M
-Change in receivables	209.98%2.05M	-130.93%-8.65M	-516.69%-5.54M	89.70%-536K	-110.95%-702K	54.00%-1.86M	-284.25%-3.74M	86.71%-899K	-1,658.08%-5.2M	1,132.37%6.41M
-Change in inventory	-598.11%-1.32M	-118.58%-998K	-100.30%-10K	-179.38%-1.35M	111.61%95K	-76.24%264K	289.29%5.37M	-14.96%3.38M	721.61%1.7M	-1,358.46%-818K
-Change in prepaid assets	-268.51%-824K	-2,187.95%-1.73M	-16.77%799K	-80.41%-2.52M	50.20%-497K	-67.83%489K	104.30%83K	-52.80%960K	67.69%-1.4M	-239.00%-998K
-Change in payables and accrued expense	22.28%-7.51M	-0.89%665K	-72.68%1.17M	10,093.22%5.9M	703.19%3.27M	-145.24%-9.67M	112.41%671K	-20.13%4.26M	97.90%-59K	-94.87%407K
-Change in other working capital	124.33%1.31M	-137.22%-47.06M	124.47%1.14M	-338.56%-35.36M	-243.29%-7.47M	-8.56%-5.37M	47.85%-19.84M	42.51%-4.65M	30.31%-8.06M	71.57%-2.18M
Cash from discontinued investing activities
Operating cash flow	66.52%-9.54M	51.70%-45.99M	116.45%2.06M	73.67%-7.13M	28.16%-12.43M	25.73%-28.48M	39.09%-95.21M	53.62%-12.49M	42.03%-27.07M	26.55%-17.3M
Investing cash flow
Cash flow from continuing investing activities	-64.25%9.14M	-51.22%37.95M	-137.31%-8.25M	226.90%17.28M	-43.07%3.35M	-42.54%25.57M	-40.00%77.79M	589.71%22.12M	-79.77%5.29M	-84.25%5.88M
Net PPE purchase and sale	36.78%-796K	19.24%-2.96M	-695.00%-636K	-18.90%-409K	62.12%-655K	16.68%-1.26M	65.75%-3.66M	93.84%-80K	87.62%-344K	53.23%-1.73M
Net investment purchase and sale	-62.96%9.94M	-49.78%40.91M	-134.31%-7.62M	214.19%17.69M	-47.40%4M	-41.69%26.83M	-41.96%81.46M	392.76%22.2M	-80.53%5.63M	-81.46%7.61M
Cash from discontinued investing activities
Investing cash flow	-64.25%9.14M	-51.22%37.95M	-137.31%-8.25M	226.90%17.28M	-43.07%3.35M	-42.54%25.57M	-40.00%77.79M	589.71%22.12M	-79.77%5.29M	-84.25%5.88M
Financing cash flow
Cash flow from continuing financing activities	37.59%7.5M	12,515.35%30.4M	16,953.54%21.66M	4,110.00%1.68M	5,266.67%1.61M	12,288.64%5.45M	-89.27%241K	45.98%127K	135.29%40K	-97.96%30K
Proceeds from stock option exercised by employees	-7.82%5.03M	7,318.67%17.88M	7,092.13%9.13M	4,110.00%1.68M	5,266.67%1.61M	12,288.64%5.45M	-89.27%241K	45.98%127K	135.29%40K	-97.96%30K
Net other financing activities	--2.48M	--12.52M	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	37.59%7.5M	12,515.35%30.4M	16,953.54%21.66M	4,110.00%1.68M	5,266.67%1.61M	12,288.64%5.45M	-89.27%241K	45.98%127K	135.29%40K	-97.96%30K
Net cash flow
Beginning cash position	44.01%73.18M	-25.26%50.82M	40.58%57.72M	-26.94%45.88M	-28.09%53.36M	-25.26%50.82M	-26.43%68M	-55.19%41.06M	-44.01%62.8M	-23.45%74.2M
Current changes in cash	179.76%7.11M	230.20%22.37M	58.49%15.46M	154.47%11.84M	34.42%-7.47M	-59.03%2.54M	29.69%-17.18M	141.27%9.76M	-5.89%-21.74M	-174.80%-11.4M
End cash Position	50.48%80.29M	44.01%73.18M	44.01%73.18M	40.58%57.72M	-26.94%45.88M	-28.09%53.36M	-25.26%50.82M	-25.26%50.82M	-55.19%41.06M	-44.01%62.8M
Free cash flow	65.26%-10.33M	50.50%-48.95M	111.29%1.42M	72.51%-7.54M	31.25%-13.09M	25.39%-29.74M	40.80%-98.88M	55.47%-12.57M	44.59%-27.41M	30.17%-19.03M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm